| Financial Year |
March 31 2023 |
| Monetary Funds |
254,288,725.05 |
| Held-for-trading Financial Assets |
366,042,756.40 |
| Notes Receivable |
106,881,698.27 |
| Accounts Receivable |
728,965,773.86 |
| Advances to Suppliers |
132,333,833.00 |
| Other Receivables |
16,600,625.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,015,799,043.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
9,381.03 |
| Other Current Assets |
16,627,014.74 |
| Total Current Assets |
2,837,933,447.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,356,314.41 |
| Long-term Equity Investment |
151,938,848.47 |
| Investment Properties |
3,287,807.50 |
| Fixed Assetes |
356,450,702.56 |
| Under-construction Projects |
14,937,163.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,982,934.30 |
| R&D expenses |
-- |
| Goodwill |
524,203,566.45 |
| Long-Term Deferred and Prepaid Expenses |
9,584,240.34 |
| Deferred Income Tax Assets |
49,078,978.64 |
| Other Non-Current Assets |
13,481,500.35 |
| Sub-Total of Non-Current Assets |
1,207,348,137.44 |
| Total Assets |
4,045,281,584.72 |
| Short-Term Loans |
578,260,849.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
367,441,003.93 |
| Accounts Payable |
391,270,625.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,217,263.56 |
| Taxes Payable |
6,494,441.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,854,338.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,066,277.95 |
| Other Current Liabilities |
31,899,343.22 |
| Sub-Total of Current Liabilities |
1,783,834,729.30 |
| Long-term Loans |
19,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,676,609.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,027,668.23 |
| Deferred Income Tax Liabilities |
1,490,156.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
56,525,639.51 |
| Total Liabilities |
1,840,360,368.81 |
| Paid-In Capital(Or Share Stock) |
494,414,437.00 |
| Capital Surplus |
1,363,811,247.06 |
| Surplus Reserve |
20,871,998.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
321,389,572.83 |
| Minority Stockholder's Interest |
-1,049,022.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,205,970,238.77 |
| Owner's Equity（Stockholder's Equity） |
2,204,921,215.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,045,281,584.72 |
